CoagulationDisorders near Neptune, NJ

Biography: Dr. James W. Lee specializes in oncology and is board certified in internal medicine and oncology. For more than 30 years, he has been treating patients. He joined the practice of Hematology Oncology Associates, SJ in 2004 and has been treating patients in the Mount Holly community since then. Dr. Lee obtained his medical degree from Cornell University Medical College. He completed his internship and residency at Georgetown University Hospital. Dr. Lee spent his fellowship at the National Cancer Institute (NCI) and continued there for 7 years in the prestigious oncology program, where he participated in basic and clinical research, prior to going into private practice. His extensive research background has helped to develop clinical research programs in private practice and in conjunction with the Virtua Fox Chase Cancer Program. Dr. Lee is a member of the American Medical Association, American Society of Clinical Oncology, and New Jersey Medical Society. Medical Education: Cornell University Medical College Residency: Georgetown University Hospital Fellowship: National Cancer Institute/Medicine Branch, Bethesda, MD Board Certifications: Internal medicine, oncology Specializations: Oncology Research Interests: Principal Investigator with cooperative clinical trial groups; coordinates investigator-sponsored and industry-sponsored clinical trials of Memberships: American Medical Society, American Society of Clinical Oncology (ASCO), New Jersey Medical Society Languages Spoken: English, some Korean

Biography: Margaret T Lee, MD cares for children with blood disorders, such as anemias (sickle cell anemia, thalassemia, and iron deficiency), bleeding (including idiopathic thrombocytopenic purpura [ITP], hemophilia, and von Willebrand disease), and clotting disorders (such as deep vein thrombosis). Dr. Lee's area of interest is a rare group of diseases called vascular anomalies. There is relatively little known about these disorders, and the care of patients with vascular anomalies requires a multidisciplinary group of physicians from several specialties (dermatology, surgery, cardiology, neurology, and hematology/oncology)-all of whom are available at NewYork-Presbyterian/Morgan Stanley Children's Hospital. Hematologists play a role in the medical treatment of vascular tumors and the supportive care of clotting and bleeding complications that are associated with some types of vascular malformations. Dr. Lee is an active participant in the Vascular Anomalies Group at NYP/Morgan Stanley Children's Hospital, as well as the Vascular Anomalies Special Interest Group of the American Society of Pediatric Hematology/Oncology, which is looking at novel therapies for vascular anomalies and their complications.

Biography: Dr. Shipra Kaicker is an Associate Professor of Clinical Pediatrics at Weill Cornell Medicine and Associate Attending Pediatrician at NewYork-Presbyterian Hospital. Her clinical areas of interest are pediatric hematology, platelet disorders, immune cytopenias, anemias, sickle cell disease and bone marrow failure syndromes. She is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Kaicker received her M.B.B.S. degree at Lady Hardinge Medical College at the University of Delhi, New Delhi, India. She completed her M.D. and Pediatric Residency at Maulana Azad Medical College, also at the University of New Delhi, where she also served as Senior Registrar (Chief Resident) in Pediatrics. Dr. Kaicker expanded her training in New York City, where she completed a Post-Doctoral Clinical Fellowship and Post-Doctoral Research Fellowship, both in Pediatric Hematology-Oncology, at Columbia University Medical Center, and an additional Pediatric Residency at Saint Vincent's Medical Center. Dr. Kaicker is a clinical researcher and is participating in clinical trials for childhood immune thrombocytopenia as part of ICON ( ITP Consortium of North America) and collaborating with basic science researchers to identify biomarkers in childhood ITP

Care Philosophy: My first priority is the patient sitting in front of me. I have a longstanding interest in cancer care and have been specifically focused on lymphoma since my father was diagnosed with Hodgkin lymphoma when I was a medical student. At Weill Cornell, our experienced team of lymphoma specialists works together to determine the most appropriate therapy for each individual patient. Our group has played a key role in the development of many new therapies approved for lymphoma in recent years. As a result, our patients have early access to new and promising lymphoma treatments. We are fortunate to have a strong team of physician assistants, nurses, medical technicians, pharmacists, and administrative staff. This environment enables me to provide my patients with the best possible level of care.